Myxoid Dermatofibrosarcoma Protuberans With Giant Cell Fibroblastoma Features in an Adult: Case Report and Review.

Int J Surg PatholMay 7, 2026 (epub)
Case ReportDermatologyOpen access

Chenxu Shi, Ahmed Lazim, Paul J Zhang

✦ AI-curated · Sources linked

Case in brief

A 32-year-old man presented with a myxoid dermatofibrosarcoma protuberans (DFSP) that exhibited features of giant cell fibroblastoma. The diagnosis was confirmed through immunohistochemistry and fluorescence in situ hybridization (FISH) for PDGFB rearrangement, underscoring the complexity of this rare presentation. The case illustrates the importance of molecular techniques in confirming atypical sarcomas.

What made this case unusual

The coexistence of myxoid DFSP with giant cell fibroblastoma features in an adult is exceptionally rare, presenting significant diagnostic challenges.

Diagnostic / clinical pearl

Clinicians should consider molecular confirmation, such as FISH for PDGFB rearrangement, when diagnosing atypical presentations of dermatofibrosarcoma protuberans.

Why it matters

This case emphasizes the need for awareness of rare DFSP variants and the role of advanced diagnostic techniques in ensuring accurate diagnosis.

Source

Published in Int J Surg Pathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Dermatology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.